RecruitingNCT05786001

Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia

Evaluation of Lower Limb Angiosome Perfusion and Oxygenation Using Thermal and Hyperspectral Imaging


Sponsor

Tampere University

Enrollment

150 participants

Start Date

Jun 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Assessment of a novel diagnostic method for screening and diagnosing chronic limb-threatening ischemia (CLTI). Using hyperspectral and thermal imaging, the perfusion and oxygenation in the lower limbs will be studied in healthy and unhealthy individuals.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at new non-invasive ways to measure blood flow in the legs of people with chronic limb-threatening ischemia (CLTI) — a serious condition where the arteries in the legs are so blocked that the limbs may be at risk. Researchers are comparing measurements in people with CLTI versus healthy people to develop better diagnostic tools. **You may be eligible if...** - You are over 50 years old and have been diagnosed with CLTI (blocked leg arteries) - OR you are over 50 with a healthy cardiovascular system (as a comparison group) - OR you are between 18 and 50 with no history of heart or blood vessel disease (as a healthy control) - You are volunteering willingly for the study **You may NOT be eligible if...** - You are unable to give informed consent - You choose not to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Tampere University

Tampere, Pirkanmaa, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05786001


Related Trials